For the quarter ending 2026-03-31, SNGX had -$1,906,723 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -2,824,965 | -2,896,189 | -2,530,947 | -5,653,244 |
| Amortization and depreciation | 1,098 | 1,002 | 911 | 1,311 |
| Non-cash lease expense | 28,025 | 27,450 | 26,889 | 60,263 |
| Share-based compensation | 121,208 | 320,125 | 104,346 | 163,112 |
| Issuance of common stock to vendors for services | 10,002 | 0 | 46,600 | 30,000 |
| Prepaid expenses and other current assets | -457,210 | 538,733 | 164,478 | -714,169 |
| Operating lease liability | -27,484 | -26,911 | -26,349 | -61,062 |
| Accounts payable and accrued expenses | 322,307 | -47,154 | -375,216 | 405,869 |
| Accrued compensation | -445,124 | 415,306 | -14,370 | -249,253 |
| Net cash flows from operating activities | -2,357,723 | -2,745,104 | -2,932,614 | -4,588,835 |
| Proceeds from issuance of common stock and pre-funded warrants | - | 0 | 7,498,522 | - |
| Purchases of furniture and equipment | - | 1,962 | 608 | 3,313 |
| Stock issuance costs associated | - | 145,866 | 562,370 | - |
| Net cash flows from investing activities | - | -1,962 | -608 | -3,313 |
| Proceeds from the exercise of warrants | - | 303,750 | 1,491 | - |
| Convertible debt repayments | - | 0 | 0 | 1,372,873 |
| Proceeds from issuance of common stock pursuant to at market issuance sales agreement | 509,277 | 0 | 1,423,244 | 3,243,177 |
| Costs associated with at market issuance sales agreement | 58,277 | - | - | - |
| Net cash flows from financing activities | 451,000 | 157,884 | 8,360,887 | 1,870,304 |
| Net decrease in cash and cash equivalents | -1,906,723 | -2,589,182 | 5,427,665 | -2,721,844 |
| Cash and cash equivalents at beginning of period | 7,936,153 | 10,525,335 | 7,819,514 | - |
| Cash and cash equivalents at end of period | 6,029,430 | 7,936,153 | 10,525,335 | - |
SOLIGENIX, INC. (SNGX)
SOLIGENIX, INC. (SNGX)